Fig. 8From: Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trialChange in BMD (%) from baseline in the three patient groups at the lumbar spine BMD AP side over 2 years. Significant differences were observed between the switch and ALD groups (P = 0.02) and between the switch and control groups (P = 0.00002)Back to article page